Bicara Therapeutics Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Operating income | -$155.6 | -$82.4 | -$39.9 | — |
| Net income | -$137.9 | -$68.0 | -$52.0 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$107.1 | -$74.8 | -$46.2 | — |
Shares outstanding 65.7M · Free float 52.5%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.